Browse by category

SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesity

Results from the SELECT cardiovascular outcomes trial has revealed that semaglutide 2.4mg demonstrated a statistically significant and...

BMS may help reduce heart failure-related risk factors

17 hours ago

GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour

2 days ago

Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours

2 days ago

Weekly Digest